Pathogenic mechanisms underlying spinocerebellar ataxia type 1

被引:19
|
作者
Tejwani, Leon [1 ,2 ]
Lim, Janghoo [1 ,2 ,3 ,4 ,5 ]
机构
[1] Yale Sch Med, Interdept Neurosci Program, 295 Congress Ave, New Haven, CT 06510 USA
[2] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA
[3] Yale Sch Med, Dept Genet, New Haven, CT 06510 USA
[4] Yale Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA
[5] Yale Sch Med, Yale Stem Cell Ctr, New Haven, CT 06510 USA
基金
美国国家卫生研究院;
关键词
Spinocerebellar ataxia; CAG; polyglutamine disorder; Repeat expansion; SCA1; ATXN1; Ataxin-1; Neurodegeneration; POLYGLUTAMINE-INDUCED DISEASE; TATA-BINDING PROTEIN; WILD-TYPE ATAXIN-1; CAG REPEAT; TRINUCLEOTIDE REPEAT; DOMINANT SPINOCEREBELLAR; HUNTINGTONS-DISEASE; HEREDITARY ATAXIA; SCA1; GENE; NEURODEGENERATIVE DISORDER;
D O I
10.1007/s00018-020-03520-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The family of hereditary cerebellar ataxias is a large group of disorders with heterogenous clinical manifestations and genetic etiologies. Among these, over 30 autosomal dominantly inherited subtypes have been identified, collectively referred to as the spinocerebellar ataxias (SCAs). Generally, the SCAs are characterized by a progressive gait impairment with classical cerebellar features, and in a subset of SCAs, accompanied by extra-cerebellar features. Beyond the common gait impairment and cerebellar atrophy, the wide range of additional clinical features observed across the SCAs is likely explained by the diverse set of mutated genes that encode proteins with seemingly disparate functional roles in nervous system biology. By synthesizing knowledge obtained from studies of the various SCAs over the past several decades, convergence onto a few key cellular changes, namely ion channel dysfunction and transcriptional dysregulation, has become apparent and may represent central mechanisms of cerebellar disease pathogenesis. This review will detail our current understanding of the molecular pathogenesis of the SCAs, focusing primarily on the first described autosomal dominant spinocerebellar ataxia, SCA1, as well as the emerging common core mechanisms across the various SCAs.
引用
收藏
页码:4015 / 4029
页数:15
相关论文
共 50 条
  • [1] Pathogenic mechanisms underlying spinocerebellar ataxia type 1
    Leon Tejwani
    Janghoo Lim
    Cellular and Molecular Life Sciences, 2020, 77 : 4015 - 4029
  • [2] Pathogenic Mechanisms of a Polyglutamine-mediated Neurodegenerative Disease, Spinocerebellar Ataxia Type 1
    Zoghbi, Huda Y.
    Orr, Harry T.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (12) : 7425 - 7429
  • [3] Molecular Mechanisms of Spinocerebellar Ataxia Type 1
    Volovikov, E. A.
    Davidenko, A. V.
    Lagarkova, M. A.
    RUSSIAN JOURNAL OF GENETICS, 2020, 56 (02) : 129 - 141
  • [4] Molecular Mechanisms of Spinocerebellar Ataxia Type 1
    E. A. Volovikov
    A. V. Davidenko
    M. A. Lagarkova
    Russian Journal of Genetics, 2020, 56 : 129 - 141
  • [5] Pathogenetic Mechanisms Underlying Spinocerebellar Ataxia Type 3 Are Altered in Primary Oligodendrocyte Culture
    Schuster, Kristen H.
    Putka, Alexandra F.
    McLoughlin, Hayley S.
    CELLS, 2022, 11 (16)
  • [6] Molecular Mechanisms of Spinocerebellar Ataxia Type 17
    Davidenko, Alina
    Bogomazova, Alexandra
    Illarioshkin, Sergey
    Lagarkova, Maria
    MOLECULAR NEUROBIOLOGY, 2024, : 5720 - 5729
  • [7] Diverse regional mechanisms drive spinocerebellar ataxia type 1 phenotypes
    Putka, Alexandra F.
    McLoughlin, Hayley S.
    NEURON, 2023, 111 (04) : 447 - 449
  • [8] Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies
    Ortiz, Judit M. Perez
    Orr, Harry T.
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 135 - 145
  • [9] Mechanisms of rapid ataxin-1 degradation in Spinocerebellar Ataxia Type 1
    Kohiyama, Mayumi
    Toker, Nicholas
    Hearing, Casey
    Lagalwar, Sara
    FASEB JOURNAL, 2015, 29
  • [10] Spinocerebellar ataxia type 1 in Russia
    Illarioshkin, SN
    Slominsky, PA
    Ovchinnikov, IV
    Markova, ED
    Miklina, NI
    Klyushnikov, SA
    Shadrina, M
    Vereshchagin, NV
    Limborskaya, SA
    IvanovaSmolenskaya, IA
    JOURNAL OF NEUROLOGY, 1996, 243 (07) : 506 - 510